List view / Grid view
Pfizer intends to appeal and seek re-examination...
25 April 2013 | By Pfizer
Pfizer intends to appeal and seek re-examination...
The U.S. FDA has extended the action date by three…
21 August 2012 | By Pfizer
The U.S. FDA has extended the action date by three months for the NDA for tofacitinib...
Tafamidis is a novel, investigational medication for the treatment of…
18 June 2012 | By Pfizer
Tafamidis is a novel, investigational medication for the treatment of TTR-FAP...
“We are pleased with the Committee’s positive evaluation..."
9 May 2012 | By Pfizer
“We are pleased with the Committee’s positive evaluation..."
